Playback speed
10 seconds
Anti-PD-L1 Therapy in Urothelial Carcinoma: What Does the Clinical Trial Data Suggest on the Use of FDA Approved Atezolizumab?
By
Stanford Medicine
FEATURING
Sandy Srinivas
By
Stanford Medicine
FEATURING
Sandy Srinivas
44 views
June 12, 2020
Login to view comments.
Click here to Login